Optimization of dietary folate or low-dose folic acid supplements lower homocysteine but do not enhance endothelial function in healthy adults, irrespective of the methylenetetrahydrofolate reductase (C677T) genotype

This publication has 31 references indexed in Scilit:

• Prognostic Impact of Coronary Vasodilator Dysfunction on Adverse Long-Term Outcome of Coronary Heart Disease
  Circulation, 2000
• Hyperhomocysteinemia Increases Risk of Death, Especially in Type 2 Diabetes
  Circulation, 2000
• Long-Term Follow-Up of Patients With Mild Coronary Artery Disease and Endothelial Dysfunction
  Circulation, 2000
• Oral folate enhances endothelial function in hyperhomocysteinaemic subjects
  European Journal of Clinical Investigation, 1999
• Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials
  BMJ, 1998
• Genes, greens, and homocysteine.
  Heart, 1996
• Relation Between Folate Status, a Common Mutation in Methylenetetrahydrofolate Reductase, and Plasma Homocysteine Concentrations
  Circulation, 1996
• A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase
  Nature Genetics, 1995
• Impaired Endothelium-Dependent Vasodilation of Large Epicardial and Resistance Coronary Arteries in Patients With Essential Hypertension
  Hypertension, 1995
• Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents
  Journal of the American College of Cardiology, 1993